Disease Characteristics and Burden in Patients With Atopic Dermatitis: Insights From Two Phase 3 Studies of Ruxolitinib Cream

被引:0
|
作者
Simpson, Eric [1 ]
Lee, Mark [2 ]
Brar, Kanwaljit [3 ]
Kuligowski, Michael [4 ]
Venturanza, May [4 ]
Sun, Kang [4 ]
Toth, Darryl [5 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Progress Clin Res, San Antonio, TX USA
[3] NYU, Grossman Sch Med, Hassenfeld Childrens Hosp, New York, NY USA
[4] Incyte Corp, Wilmington, DE USA
[5] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
108
引用
收藏
页码:AB35 / AB35
页数:1
相关论文
共 50 条
  • [21] Effects of ruxolitinib cream on pruritus in black patients with atopic dermatitis
    Eichenfield, L. F.
    Gold, L. F. Stein
    Brar, K. K.
    Fuxench, Z. C. Chiesa
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Szepietowski, J. C.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S49 - S49
  • [22] Long-term safety and disease control with ruxolitinib cream in patients with atopic dermatitis based on previous medication history: pooled results from two phase III studies
    Blauvelt, A.
    Eichenfield, L. F.
    Kuligowski, M. E.
    Venturanza, M. E.
    Sun, K.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E136 - E137
  • [23] Effects of ruxolitinib cream on pruritus and sleep in atopic dermatitis: 52-week pooled results from two phase III studies
    Simpson, E. L.
    Boguniewicz, M.
    Thaci, D.
    Misery, L.
    Armstrong, A. W.
    Silverberg, J. I.
    Venturanza, M. E.
    Kallender, H.
    Gao, J.
    Szepietowski, J. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E166 - E167
  • [24] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from two phase III randomized double-blind studies
    Papp, K.
    Szepietowski, J. C.
    Kircik, L.
    Toth, D.
    Kuligowski, M. E.
    Venturanza, M.
    Sun, K.
    Simpson, E.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E116 - E117
  • [25] Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies
    Eichenfield, Lawrence F.
    Gold, Linda F. Stein
    Fuxench, Zelma C. Chiesa
    Venturanza, May E.
    Ren, Haobo
    Brar, Kanwaljit K.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB180 - AB180
  • [26] Effects of ruxolitinib cream on work productivity and activity impairment in patients with atopic dermatitis: 52-week pooled results from two phase III studies
    Eichenfield, Lawrence F.
    Augustin, Matthias
    Armstrong, April W.
    Venturanza, May E.
    Kallender, Howard
    Gao, Jessy
    Silverberg, Jonathan I.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E126 - E127
  • [27] Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
    Bloudek, Lisa
    Eichenfield, Lawrence F.
    Silverberg, Jonathan, I
    Joish, Vijay N.
    Lofland, Jennifer H.
    Sun, Kang
    Augustin, Matthias
    Migliaccio-Walle, Kristen
    Sullivan, Sean D.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (01) : 109 - 117
  • [28] Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
    Lisa Bloudek
    Lawrence F. Eichenfield
    Jonathan I. Silverberg
    Vijay N. Joish
    Jennifer H. Lofland
    Kang Sun
    Matthias Augustin
    Kristen Migliaccio-Walle
    Sean D. Sullivan
    American Journal of Clinical Dermatology, 2023, 24 : 109 - 117
  • [29] Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies
    Simpson, Eric L.
    Kircik, Leon
    Blauvelt, Andrew
    Kallender, Howard
    Sturm, Daniel
    Wang, Mingyue
    Eichenfield, Lawrence F.
    DERMATOLOGY AND THERAPY, 2024, 14 (08) : 2139 - 2151
  • [30] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Leung, Donald Y. M.
    Forman, Seth B.
    Venturanza, May E.
    Sun, Kang
    Kuligowski, Michael E.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 863 - 872